Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 27, Issue 35, Pages 3714-3721Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612827666210614102340
Keywords
Biomarker; cardiovascular disease; circulating micro-RNA; EV; micro RNA; nanoparticle; stem cell therapy; troponin; acute my-ocardial disease
Categories
Ask authors/readers for more resources
Extracellular vesicles, also known as exosomes, are small membrane-bound particles that play a significant role in cellular communication by transporting various molecules. Their potential in diagnosing and treating cardiovascular diseases has a bright future, offering new possibilities in cardiology medicine. They can serve as valuable biomarkers and natural drug-delivery vehicles for targeted treatments in myocardial injury and repair.
Extracellular vesicles (EVs, formerly known as exosomes) are small, extracellular membrane-bound particles that play a role in cellular communication via transporting different cargos, including proteins, DNAs, RNAs, etc. Their role has been shown in different endocrine/paracrine signaling in different organs, such as the cardiovascular system. Currently, mortality and morbidity rates caused by cardiovascular disease (CVD) have become an important issue among healthcare systems all over the world. EVs great potentials for clinical diagnosis and treatment offer a bright future in assessing different types of CVDs. In this review, we have summarized the variable roles of these nano-sized biological membrane-enclosed vesicles in myocardial injury, repair, and regeneration. We have also reviewed the value of EVs as diagnostic and prognostic biomarkers in cardiology medicine and emphasized the promising capabilities of EVs as natural drug-delivery vehicles as a novel targeting treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available